The Neuropathology Core (NC) provides diagnostic services, sets up, and maintains a collection of brain samples, and supplies samples for research to investigators of the Center, affiliated Centers, and to outside neuroscientists conducting research into neurodegenerative diseases. Because humans are the only species to naturally develop AD the availability of postmortem samples for human tissue-dependent studies is essential despite the existence of transgenic animal models. We designed a standard protocol with built in flexibility to accommodate studies with specific aims, as the ones proposed by Project 3. Precisely identified samples, obtained from one half brain, are fresh frozen in liquid nitrogen vapor, and are electronically tracked. The contralateral half brain is used for 1)the diagnostic category, 2)teaching, and 3)research using formalin fixed samples. The postmortem findings are recorded within two standardized reports; a)text-based medical files, and b)quantification-based report, providing data to the Clinical Core/Data Management, and to NACC in compliance with NIA requirements. The categorization of both fresh frozen or fixed samples must be as accurate as possible. To optimize the diagnostic categorization a clinicopathological correlation is performed for each brain in collaboration with the Clinical Core. Once diagnostically categorized the postmortem brain samples are made available to neuroscientists quickly following receipt of a request. A subset of sample is provided to the Genetics Core for molecular dependent studies, and for the DNA library. Brain banking cannot be achieved at the cost of the teaching mission of academic institutions by routing brains away from residency programs when the autopsy rate is decreasing. Thus, while securing the standardization of processing, the evaluation of brains is combined with teaching the pathological changes of neurodegeneration to residents and fellows especially of the Pathology service. In contrast, emphasis on the differential clinical phenotypes of neurodegenerative diseases is achieved during the clinicopathological conferences, which are conducted monthly, with the Clinical Core and Education Core, and by caregivers involved directly with patients. Etty Paola Cortes Ramirez, MD, is a trainee participating in all tasks of the brain bank. Two Fellows, Drs. J. Valentin and H. Varma are in training including the neuropathology of neurodegenerative diseases. Renpei Sengoku,MD,PhD, learned in situ our methods of brain banking, and is implementing them at the Jikei University School of Medicine, Tokyo, Japan. We trained scientists and shared our experience and methods of processing brains and storing fresh frozen samples with the Southern Arizona VA Health Care System. We help implement our electronic tracking system at the National Prion Disease Pathology Surveillance Center- Case Western Reserve University, and at the Neuropathology and Prion Research Ludwig Maximilian University of M?nich.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG008702-28
Application #
9318384
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2017-06-01
Budget End
2018-05-31
Support Year
28
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Gallagher, Damien; Kiss, Alex; Lanctot, Krista L et al. (2018) Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors. J Clin Psychiatry 80:
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Bravo, Francisca Vaz; Da Silva, Jorge; Chan, Robin Barry et al. (2018) Phospholipase D functional ablation has a protective effect in an Alzheimer's disease Caenorhabditis elegans model. Sci Rep 8:3540
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Grivel, Margaux M; Leong, Wei; Masucci, Michael D et al. (2018) Impact of lifetime traumatic experiences on suicidality and likelihood of conversion in a cohort of individuals at clinical high-risk for psychosis. Schizophr Res 195:549-553
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600

Showing the most recent 10 out of 640 publications